HEMANGIOPERICYTOMA
Clinical trials for HEMANGIOPERICYTOMA explained in plain language.
Never miss a new study
Get alerted when new HEMANGIOPERICYTOMA trials appear
Sign up with your email to follow new studies for HEMANGIOPERICYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers? drug combo shows promise in early trial
Disease control OngoingThis phase 2 study tests two drugs, sunitinib and temsirolimus, in 137 people with advanced rare tumors that have no cure. The goal is to see if these drugs can shrink tumors or slow their growth. Participants take one of the two drugs, and researchers measure how long the cancer…
Matched conditions: HEMANGIOPERICYTOMA
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Brain radiation and memory: new study maps hidden risks
Knowledge-focused OngoingThis study follows 75 adults with benign or slow-growing brain tumors who are receiving partial brain radiation. Researchers will use memory tests and MRI scans before treatment and at 6 and 12 months after to see how radiation affects thinking and memory. The goal is to identify…
Matched conditions: HEMANGIOPERICYTOMA
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC